Researchers find promising new way to boost the immune response to cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 8-Jan-2026 06:11 ET (8-Jan-2026 11:11 GMT/UTC)
Researchers at the University of Southampton have developed a promising new way to bolster the body’s immune system response to cancer.
In a study published in Nature Communications, researchers used specially engineered multi-pronged antibodies to better activate cancer-killing T cells.
The antibodies work by ‘grabbing’ and ‘clustering’ multiple immune cell receptors – boosting the signal which tells the T cell to attack the cancer.
Two new studies published in Anaesthesia (the journal of the Association of Anaesthetists) analysing pain and other factors connected with day surgery in the UK show that around 1 in 8 patients having day-case surgery end up not going home and instead are admitted to hospital for various complications. Furthermore, one in 14 go on to develop chronic pain at the operative site after the procedure.
BATF2 is a new type of tumor suppressor that can be epigenetically silenced by high levels of glutamine in the tumor microenvironment
Glutamine silences BATF2 and leads to a weakened immune response
Blocking glutamine reverses these effects, increasing BATF2 expression and improving overall immunity
Adolescent and young adult cancer survivors age faster than their peers who did not have cancer, according to a new study, which also describes how accelerated aging occurs both at the cellular level and in brain function, such as memory, attention, and ability to process information.